John F. Kurland/LinkedIn
Apr 2, 2025, 09:58
John F. Kurland presented about immuno-oncology therapies at the IO360 Summit
John F. Kurland, VP of Global Head of Strategic Regimens at AstraZeneca, posted on LinkedIn:
“I am excited to report back from Boston and the IO360 Summit, where I spoke about advancements in immuno-oncology therapies.
This event offered a valuable opportunity to interact with colleagues, to learn about emerging approaches, and to explore ways of collaborating in our mission to improve patient outcomes.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 3, 2025, 11:22
Sep 3, 2025, 11:19
Sep 3, 2025, 11:17
Sep 3, 2025, 11:09
Sep 3, 2025, 10:35
Sep 3, 2025, 10:18